Literature DB >> 19479943

Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.

Masakuni Noguchi1, Masashi Inokuchi, Yo Zen.   

Abstract

BACKGROUND: The optimal site for injection of mapping tracers is controversial in sentinel lymph node (SLN) biopsy for breast cancer. We evaluated whether a combination of peritumoral (PT) injection and subareolar (SA) injection can improve the identification rate of SLN biopsy and decrease the false-negative rate.
METHODS: Two hundred one patients underwent SLN biopsy with PT injection of radioisotope and SA injection of blue dye.
RESULTS: The overall identification rate for blue and/or hot lymph nodes was 99.5%; the identification rate of blue-dyed lymph nodes was 98.0% and that of hot lymph nodes was 97.0%. However, no concordance between the hot node and the blue node was found in 17 patients (8.5%). Among SLN-positive 51 patients, 4 patients had blue-only positive SLN and 7 had hot-only positive SLN. Consequently, the false-negative rates were at least 7.8% for PT injection and 13.7% for SA injection, while axillary lymph node dissection was not performed in SLN-negative patients. However, a combination of both injections significantly decreased the false-negative rate.
CONCLUSIONS: The success of SLN mapping is optimized not only by using dye and isotope in combination but also by using PT and SA injections in combination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479943     DOI: 10.1002/jso.21308

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

1.  Sentinel Lymph Node Biopsy After Initial Lumpectomy (SNAIL Study)-a Prospective Validation Study.

Authors:  Sanjit Kumar Agrawal; Lalit Bansawal; Indu Arun; Soumtira Shankar Datta; Sanjoy Chatterjee; Rosina Ahmed
Journal:  Indian J Surg Oncol       Date:  2018-12-18

Review 2.  Current status of sentinel lymph-node biopsy in patients with breast cancer.

Authors:  Gang Cheng; Stephanie Kurita; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-11       Impact factor: 9.236

3.  The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.

Authors:  Francesco Giammarile; Naomi Alazraki; John N Aarsvold; Riccardo A Audisio; Edwin Glass; Sandra F Grant; Jolanta Kunikowska; Marjut Leidenius; Valeria M Moncayo; Roger F Uren; Wim J G Oyen; Renato A Valdés Olmos; Sergi Vidal Sicart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-02       Impact factor: 9.236

4.  Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye.

Authors:  Wenbin Guo; Li Zhang; Jun Ji; Wei Gao; Jintao Liu; Meng Tong
Journal:  Tumour Biol       Date:  2013-12-05

5.  Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green.

Authors:  Kei Aoyama; Takako Kamio; Tetsuya Ohchi; Masako Nishizawa; Shingo Kameoka
Journal:  World J Surg Oncol       Date:  2011-12-02       Impact factor: 2.754

Review 6.  Nodal status assessment in breast cancer: strategies of clinical grounds and quality of life implications.

Authors:  Paolo Orsaria; Dimitrios Varvaras; Gianluca Vanni; Giampiero Pagnani; Jacopo Scaggiante; Federico Frusone; Alessandra Vittoria Granai; Giuseppe Petrella; Oreste Claudio Buonomo
Journal:  Int J Breast Cancer       Date:  2014-02-11

7.  Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.

Authors:  Wenbin Guo; Li Zhang; Jun Ji; Wei Gao; Jintao Liu; Meng Tong
Journal:  World J Surg Oncol       Date:  2014-09-20       Impact factor: 2.754

8.  Use of Fluorescence Imaging in Combination with Patent Blue Dye versus Patent Blue Dye Alone in Sentinel Lymph Node Biopsy in Breast Cancer.

Authors:  Meng Tong; Wenbin Guo; Wei Gao
Journal:  J Breast Cancer       Date:  2014-09-30       Impact factor: 3.588

9.  Sentinel node mapping for breast cancer: current situation.

Authors:  Sergi Vidal-Sicart; Renato Valdés Olmos
Journal:  J Oncol       Date:  2012-08-15       Impact factor: 4.375

10.  A novel finding of sentinel lymphatic channels in early stage breast cancer patients: which may influence detection rate and false-negative rate of sentinel lymph node biopsy.

Authors:  Minghai Wang; Wenbin Zhou; Yingchun Zhao; Tiansong Xia; Xiaoming Zha; Qiang Ding; Xiaoan Liu; Yi Zhao; Lijun Ling; Lin Chen; Shui Wang
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.